Selected passages from the FDA letter
Quoted FDA text from the published dataset. These selected excerpts are not the complete letter.
Passage 1FDA laboratory testing of a batch of this product in U.S. distribution found that the drug product contained impurities at unacceptable levels. Benzene impurity levels were found to be approximately 6 parts per million (ppm).
Passage 2In response to FDA’s request during the teleconference for impurity testing results, you responded in a December 29, 2021 communication, stating that you do not conduct impurity testing, including for benzene, of active pharmaceutical ingredients or for your finished hand sanitizer drug products.
Passage 3As of the date of this letter, you have yet to initiate a recall.
Citations in the original letter
As cited in this historical letter, not a statement of current regulatory requirements.
- 21 CFR 211.160(b)
- 21 CFR 211.165